{"filing":{"accession_number":"0001493152-26-029570","cik":"0001575858","ticker":"PUBC","company_name":"Purebase Corp","form":"8-K","filing_date":"2026-06-22","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1575858/000149315226029570/form8-k.htm"},"events":[{"id":12906,"run_id":11451,"accession_number":"0001493152-26-029570","anchor_item_number":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"The filing discloses under Item 5.02 that the board approved annual compensation of $150,000 for Dr. Amy T. Clemens, who was recently appointed as Chief Financial Officer on June 4, 2026. While the appointment itself occurred previously, the principal disclosed action in this 8-K is the board's approval of her compensatory arrangement, making this an executive compensation disclosure rather than an appointment event.","company_name":"Purebase Corp","ticker":"PUBC","filing_date":"2026-06-22","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":9893,"accession_number":"0001493152-26-029570","item_number":null,"item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The filing discloses under Item 5.02 that the board approved annual compensation of $150,000 for Dr. Amy T. Clemens, who was recently appointed as Chief Financial Officer on June 4, 2026. While the appointment itself occurred previously, the principal disclosed action in this 8-K is the board's approval of her compensatory arrangement, making this an executive compensation disclosure rather than an appointment event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T03:32:27.619102+00:00","company_name":"Purebase Corp","ticker":"PUBC","filing_date":"2026-06-22"}]}